A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT03312530 · COMPLETED
Trial details
- NCT number
- NCT03312530
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-13
- Primary completion
- 2021-05-18
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.